結紮器市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、施術タイプ別、最終用途別、地域別、競合別、2019年～2029年

結紮器の世界市場は2023年に12億3,000万米ドルと評価され、2029年までのCAGRは6.21%で、予測期間には目覚ましい成長が予測されています。

世界の結紮市場は、慢性疾患の有病率の上昇、外科手術の増加、医療技術の進歩に牽引され、近年著しい成長を遂げています。結紮器は、一般外科、婦人科、泌尿器科、心臓血管外科など、さまざまな診療科で重要な役割を担っており、幅広い需要に貢献しています。結紮器は、様々な外科手術や医療処置において、血管やチューブ、その他の構造物を縛ったり固定したりするために使用される医療用具や器具です。これらの器具は一般的に出血を防ぎ、血管を閉鎖し、永久的または一時的な閉鎖を作るために使用されます。結紮器は、機械的タイプと吸収性タイプの2つに大別されます。機械的な結紮器は、金属やプラスチックなどの素材でできており、血管や組織を物理的に挟んだり、縛ったりするように設計されています。永久的な閉鎖が必要な手術によく使用されます。機械的結紮器の例としては、ヘモクリップ、結紮クリップ、結紮ループなどがあります。吸収性結紮器は、時間の経過とともに分解または体内に吸収される材料で作られています。一時的な閉鎖や体内に留置する必要のない処置によく使用されます。吸収性結紮器の例としては、縫合糸、止血剤、血管プラグなどがあります。結紮市場拡大の主な促進要因の一つは、人口の高齢化とそれに伴う心血管疾患、がん、肥満などの慢性疾患の急増です。これらの疾患では外科的治療が必要となることが多く、止血や組織・血管の固定には結紮器が重要です。正確で効果的な結紮器具を必要とする低侵襲手術の採用が増加していることが、これらの器具の需要をさらに高めています。技術の進歩により、効率性の向上、合併症リスクの低減、患者の転帰の改善を実現する革新的な結紮器が開発されています。例えば、吸収性結紮器の出現は、長期間の留置が不要な処置に代替手段を提供しました。これらの器具は体内で徐々に分解されるように設計されているため、追加の除去処置の必要性がなくなります。先進国、新興経済諸国ともに結紮器の需要が増加しているため、市場成長は特定の地域に限定されないです。しかし、北米と欧州は、確立されたヘルスケア・インフラ、高い医療費、先進医療技術の早期導入により、依然として有力な市場です。したがって、世界の結紮市場は、慢性疾患の有病率の増加、外科手術の増加、技術革新などの要因により、力強い成長を遂げています。結紮器は、様々な医療処置において止血と組織閉鎖を達成するために不可欠なツールであり続けています。医療技術が進化し続け、ヘルスケアシステムが患者ケアの強化に努める中、結紮市場は上昇基調を維持すると予想されます。

市場促進要因

慢性疾患の有病率の上昇

低侵襲手術の増加

外科手術の増加

主な市場課題

結紮器の高コスト

ヘルスケアへのアクセス制限

主な市場動向

低侵襲技術

持続可能性と環境への配慮

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の結紮器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（アプライヤ、アクセサリ）
  • 用途別（消化器・腹部外科、婦人科外科、心臓胸部外科、泌尿器科外科、その他）
  • 手術タイプ別（MIS、開腹手術）
  • 用途別（病院、外来手術センター）
  • 地域別
  • 企業別（2023）
• 市場マップ

第6章 北米の結紮器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 用途別
  • 施術タイプ別
  • 最終用途別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の結紮器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 用途別
  • 施術タイプ別
  • 最終用途別
  • 国別
• 欧州：国別分析
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の結紮器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 用途別
  • 施術タイプ別
  • 最終用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア

第9章 南米の結紮器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 用途別
  • 施術タイプ別
  • 最終用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの結紮器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 用途別
  • 施術タイプ別
  • 最終用途別
  • 国別
• 中東・アフリカ：国別分析
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収（該当する場合）
• 製品の発売（該当する場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Medtronic Plc
• The Cooper Companies, Inc.
• Conmed Corporation
• B Braun Melsungen AG
• Teleflex Incorporated
• Olympus Corporation
• Ethicon, Inc.
• Sinolinks Medical Innovatoin, Inc.
• Duomed Group
• Leo Medical Co.,Ltd.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Ligation Devices Market was valued at USD 1.23 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.21% through 2029. The global ligation market has witnessed significant growth in recent years, driven by the rising prevalence of chronic diseases, increasing surgical procedures, and advancements in medical technology. Ligation devices play a pivotal role in various medical specialties, including general surgery, gynecology, urology, and cardiovascular surgery, contributing to their widespread demand. Ligation devices are medical tools or instruments used in various surgical and medical procedures to tie off or secure blood vessels, tubes, or other structures. These devices are commonly used to prevent bleeding, close off blood vessels, and create permanent or temporary closures. Ligation devices can be broadly classified into two main types: mechanical and absorbable. The mechanical ligation devices are made of materials like metal or plastic and are designed to physically clamp or tie off vessels or tissue. They are often used in surgeries where permanent closure is desired. Examples of mechanical ligation devices includes hemoclips, ligating clips, ligating loops, etc. The absorbable ligation devices are made from materials that break down or get absorbed by the body over time. They are often used in procedures where the closure is temporary or where the device does not need to remain in the body. Examples of absorbable ligation devices includes sutures, hemostatic agents, vascular plugs, etc. One of the key drivers of the ligation market's expansion is the growing aging population and the associated surge in chronic conditions such as cardiovascular diseases, cancer, and obesity. These conditions often necessitate surgical interventions, where ligation devices are crucial for achieving hemostasis and securing tissues and vessels. The increasing adoption of minimally invasive procedures, which require precise and effective ligation tools, has further fueled the demand for these devices. Technological advancements have led to the development of innovative ligation devices that offer improved efficiency, reduced risk of complications, and enhanced patient outcomes. For instance, the emergence of absorbable ligation devices has provided an alternative for procedures where long-term implantation is unnecessary. These devices are designed to gradually degrade within the body, eliminating the need for additional removal procedures. Geographically, the market growth is not limited to a specific region, as both developed and developing economies are witnessing an uptick in demand for ligation devices. However, North America and Europe remain prominent markets due to established healthcare infrastructure, higher healthcare expenditure, and early adoption of advanced medical technologies. Therefore, the global ligation market is experiencing robust growth due to factors such as the increasing prevalence of chronic diseases, rising surgical procedures, and technological innovations. Ligation devices continue to be essential tools for achieving hemostasis and tissue closure in various medical procedures. As medical technology continues to evolve and healthcare systems strive to enhance patient care, the ligation market is expected to maintain its upward trajectory.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases has a significant impact on the global ligation market. Chronic diseases, such as cardiovascular diseases, diabetes, and cancer, are characterized by prolonged and often progressive health conditions that require medical intervention. As these conditions become more prevalent worldwide, the demand for surgical procedures involving ligation devices increases. Chronic diseases often necessitate surgical interventions for treatment, diagnosis, or symptom management. Ligation devices play a crucial role in these procedures by enabling hemostasis and tissue closure. For example, in cardiovascular surgeries, ligation devices are used to close off blood vessels or secure tissue during bypass procedures. In cancer surgeries, they help manage bleeding during tumor resection. The growing burden of chronic diseases fuels the need for medical interventions that rely on ligation devices for effective treatment outcomes. Healthcare providers and surgeons are increasingly relying on these devices to control bleeding and ensure safe surgical procedures. As the global population continues to age and chronic diseases become more common, the demand for ligation devices is expected to remain robust, driving innovation and growth in the global ligation market.

Increase in Minimally Invasive Procedures

The increase in minimally invasive procedures has a direct and significant impact on the global ligation market. Minimally invasive procedures are medical interventions that involve smaller incisions, reduced tissue trauma, and shorter recovery times compared to traditional open surgeries. This trend is driven by patient preferences for quicker recovery and reduced scarring, as well as advancements in medical technology. Ligation devices play a pivotal role in minimally invasive procedures by providing precise and efficient hemostasis and tissue closure through small incisions. As these procedures become more widespread across various medical specialties, including general surgery, gynecology, and urology, the demand for specialized ligation tools tailored to minimally invasive techniques increase. The adoption of minimally invasive approaches requires ligation devices that are compatible with smaller incisions and offer enhanced maneuverability. Manufacturers are responding to this demand by developing innovative devices such as smaller clips, absorbable sutures, and specialized hemostatic agents designed to facilitate effective closure in these procedures. The global ligation market benefits from the growing popularity of minimally invasive procedures, as it drives the need for advanced ligation solutions that cater to these techniques. The market's response to this trend involves the development of devices that not only enable successful tissue closure but also align with the goals of minimizing patient trauma and optimizing surgical outcomes in minimally invasive settings.

Growing Surgical Procedures

The growth in surgical procedures has a significant impact on the global ligation market. Surgical interventions are crucial for diagnosing, treating, and managing a wide range of medical conditions. As the global population continues to expand and age, the demand for surgical procedures across various medical specialties increases, directly driving the need for ligation devices. Ligation devices are essential tools in surgical procedures as they ensure controlled hemostasis and secure tissue closure, minimizing the risk of post-operative bleeding and complications. With the rise in surgical volumes, the demand for these devices grows proportionately. From routine procedures to complex surgeries, ligation devices play a critical role in facilitating successful outcomes. Procedures such as tumor resections, organ transplants, and cardiovascular surgeries rely on precise and effective ligation techniques to manage blood vessels and tissues. As healthcare systems evolve to accommodate the growing demand for surgical interventions, the global ligation market continues to thrive. Manufacturers are investing in research and development to innovate and improve ligation devices, catering to the diverse needs of various surgical procedures. The trend of increasing surgical procedures underscores the importance of ligation devices in modern medicine, ensuring safe and effective surgical outcomes across a wide spectrum of medical conditions.

Key Market Challenges

High Cost of Ligation Devices

The high cost of ligation devices represents a significant restraint within the global ligation market. Advanced technology, intricate design, and precision engineering contribute to the elevated cost of these medical devices. This cost factor can impact various aspects of the market. The affordability of ligation devices can influence their adoption rates. Patients, particularly those without comprehensive health insurance coverage, may face challenges accessing these devices due to their high price points. Healthcare systems in regions with limited budgets might prioritize other essential medical expenditures over the acquisition of expensive ligation devices. The cost can affect the financial feasibility of medical facilities, particularly those in resource-constrained settings. Hospitals and clinics may need to allocate substantial portions of their budgets to acquire these devices, potentially compromising their ability to invest in other critical medical equipment and services. Manufacturers also face challenges related to pricing their products competitively while covering their research, development, production, and distribution costs. Intense competition among manufacturers, driven by the desire to capture market share, can lead to price pressures that may impact profit margins and potentially deter investment in research and innovation. To address these challenges, stakeholders in the ligation market, including manufacturers, healthcare policymakers, and regulatory bodies, may need to collaborate to find ways to balance the need for innovation with affordability. This could involve exploring cost-efficient manufacturing methods, encouraging transparent pricing structures, and considering reimbursement strategies that ensure patients have access to these crucial devices without compromising the financial stability of healthcare systems.

Limited Access to Healthcare

Limited access to healthcare is a significant constraint with implications for the global ligation market. Access to quality healthcare services can be hindered by various factors such as geographic location, socioeconomic status, infrastructure, and disparities in healthcare delivery. In regions with limited access to healthcare, there may be challenges in both providing and receiving surgical interventions that involve ligation devices. Patients residing in remote or underserved areas might lack proximity to medical facilities equipped to perform these procedures. The absence of trained medical professionals and inadequate healthcare infrastructure can further exacerbate the problem, leading to delayed or denied access to necessary treatments. As a result, the demand for ligation devices could be suppressed in these areas, impacting the market's growth. Patients and healthcare providers might resort to alternative treatments or choose to forgo surgical interventions due to logistical difficulties. The lack of access to proper healthcare services can lead to suboptimal patient outcomes and reduced utilization of medical devices like ligation tools. Addressing limited access to healthcare requires comprehensive efforts, including improving healthcare infrastructure, expanding medical facilities, and training healthcare professionals in underserved regions. Telemedicine and mobile clinics are some solutions that can help bridge the gap. Collaborative initiatives between governments, non-governmental organizations, and healthcare companies can work towards improving access, ultimately benefiting both patients and the ligation market by creating a more equitable environment for medical interventions.

Key Market Trends

Minimally Invasive Techniques

Minimally invasive techniques have revolutionized surgical approaches, significantly impacting the global ligation devices market. These techniques involve performing surgeries through small incisions, utilizing specialized instruments and imaging technologies to minimize tissue trauma and enhance patient recovery. This trend has profound implications for ligation procedures and the devices used within them. In minimally invasive procedures, ligation devices play a crucial role in achieving precise hemostasis and secure tissue closure. The demand for ligation tools compatible with these techniques has led to the development of devices that can be inserted through smaller incisions while ensuring effective closure. This has spurred innovations such as smaller clips, finer sutures, and more intricate mechanisms that allow surgeons to work within confined spaces. The benefits of minimally invasive techniques, including reduced pain, shorter hospital stays, and quicker return to normal activities, have driven their widespread adoption across various medical specialties. Consequently, the global ligation devices market has evolved to provide solutions tailored to these techniques. Manufacturers are focusing on producing devices that offer optimal performance while minimizing invasiveness, aligning with the goals of minimizing patient trauma and optimizing surgical outcomes. As minimally invasive procedures continue to gain prominence, the market for ligation devices is expected to witness continued growth driven by the demand for specialized tools that cater to these techniques. The symbiotic relationship between minimally invasive techniques and ligation devices underscores the importance of innovation in the medical device industry, enhancing patient care and surgical outcomes on a global scale.

Sustainability and Environmental Considerations

Sustainability and environmental considerations are emerging as important factors in the global ligation devices market. As healthcare industries worldwide recognize the environmental impact of medical practices, there is a growing emphasis on creating more eco-friendly and sustainable solutions, including ligation devices. The production, use, and disposal of medical devices contribute to resource consumption and waste generation. In response, manufacturers are exploring ways to reduce the environmental footprint of ligation devices. This includes using biodegradable and recyclable materials, optimizing manufacturing processes to minimize energy consumption, and designing devices with longer lifespans to reduce the need for frequent replacements. Healthcare institutions and providers are increasingly incorporating sustainability into their purchasing decisions. They are seeking out products and devices that align with their commitment to environmentally responsible practices. This trend extends to the ligation devices market, where healthcare facilities are looking for options that not only meet clinical needs but also adhere to their sustainability goals. The integration of sustainability practices into the ligation devices market reflects a broader shift towards greener healthcare. As more stakeholders recognize the potential benefits of reducing waste, conserving resources, and mitigating environmental impacts, the demand for sustainable ligation solutions is expected to increase. Manufacturers that prioritize eco-friendly practices may find themselves better positioned in a market that values not only clinical effectiveness but also responsible environmental stewardship.

Segmental Insights

Application Insights

In 2023, the ligation devices market was dominated by the gastrointestinal and abdominal surgery segment and is predicted to continue expanding over the coming years. This is attributed due to the increasing occurrence of diseases associated with aging, combined with the growing need for ligation devices in the treatment and diagnosis of gastrointestinal procedures, is a significant trend. Gastrointestinal and abdominal surgeries often require the use of ligation devices for hemostasis, tissue sealing, and vessel occlusion. These procedures include gastrointestinal resections, appendectomies, cholecystectomies, hernia repairs, and bariatric surgeries, among others. Ligation devices are essential tools in these surgeries for sealing blood vessels, ligating tissue structures, and reducing intraoperative bleeding, thereby facilitating safe and efficient surgical outcomes.

Gastrointestinal and abdominal surgeries are among the most commonly performed surgical procedures globally, driven by the high prevalence of gastrointestinal diseases, such as colorectal cancer, inflammatory bowel disease, and gastroesophageal reflux disease (GERD). As the incidence of these conditions continues to rise, there is a growing demand for surgical interventions, including minimally invasive and robotic-assisted procedures, which often require the use of ligation devices.

Product Insights

In the Global Ligation Devices Market, the segment dominated by accessories is particularly noteworthy. Accessories play a pivotal role in the overall efficacy and functionality of ligation devices, complementing the primary instruments and enhancing their performance. These accessories encompass a wide range of components and ancillary products essential for various ligation procedures, including clips, cartridges, reloads, handles, and applicators. The dominance of the accessories segment can be attributed to several key factors. The versatility and adaptability of accessories enable healthcare professionals to customize their ligation procedures according to patient-specific needs and procedural requirements. With a diverse range of accessories available, clinicians can choose the most suitable components for different anatomical structures, surgical techniques, and clinical scenarios, thereby optimizing outcomes and patient safety.

Accessories often undergo rigorous testing and validation to ensure compatibility, reliability, and performance consistency with ligation devices. This stringent quality assurance process instills confidence among healthcare providers regarding the safety and effectiveness of accessories, driving their widespread adoption and usage in clinical practice. The continuous innovation and technological advancements in accessory design and functionality contribute to their dominance in the ligation devices market. Manufacturers are constantly introducing novel features, materials, and configurations to enhance the usability, ergonomics, and performance of accessories, thereby meeting the evolving needs and preferences of healthcare professionals.

Regional Insights

North America accounted for the largest revenue share in 2023. This is ascribed due to advanced healthcare infrastructure, stringent regulatory environment, emphasis on patient safety and quality of care, and the presence of key players. The greater affordability of healthcare services and relatively higher disposable incomes enable individuals to pursue gynecomastia treatments more easily. North America has a well-established healthcare infrastructure with a high prevalence of gastrointestinal and cardiovascular diseases, which are among the primary indications for ligation procedures. The region boasts a large number of hospitals, ambulatory surgery centers, and specialized healthcare facilities equipped with advanced surgical technologies and a skilled workforce capable of performing complex ligation procedures. North America is home to a significant number of medical device manufacturers and technology companies specializing in surgical devices and equipment. These companies innovate and develop a wide range of ligation devices tailored to the specific needs of healthcare providers and patients in the region. The availability of diverse product offerings and advanced technologies contributes to the widespread adoption of ligation devices in North America.

Key Market Players

Medtronic Plc

The Cooper Companies, Inc.

Conmed Corporation

B Braun Melsungen AG

Teleflex Incorporated

Olympus Corporation

Ethicon, Inc.

Sinolinks Medical Innovatoin, Inc.

Duomed Group

Leo Medical Co.,Ltd.

Report Scope:

In this report, the Global Ligation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ligation Devices Market, By Product:

Appliers Accessories

Ligation Devices Market, By Application:

Gastrointestinal and abdominal surgery Gynecological surgery Cardiothoracic surgery Urological Surgery Others

Ligation Devices Market, By Procedure Type:

MIS Open Surgery

Ligation Devices Market, By End-use:

Hospitals Ambulatory Surgical Centers

Ligation Devices Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ligation Devices Market.

Available Customizations:

Global Ligation Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Ligation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Appliers, Accessories)
  • 5.2.2. By Application (Gastrointestinal and abdominal surgery, Gynecological surgery, Cardiothoracic surgery, Urological Surgery, Other)
  • 5.2.3. By Procedure Type (MIS, Open Surgery)
  • 5.2.4. By End-use (Hospitals, Ambulatory Surgical Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2023)
• 5.3. Market Map

6. North America Ligation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Procedure Type
  • 6.2.4. By End-use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ligation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Procedure Type
      • 6.3.1.2.4. By End-use
  • 6.3.2. Canada Ligation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Procedure Type
      • 6.3.2.2.4. By End-use
  • 6.3.3. Mexico Ligation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Procedure Type
      • 6.3.3.2.4. By End-use

7. Europe Ligation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Procedure Type
  • 7.2.4. By End-use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Ligation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Procedure Type
      • 7.3.1.2.4. By End-use
  • 7.3.2. France Ligation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Procedure Type
      • 7.3.2.2.4. By End-use
  • 7.3.3. United Kingdom Ligation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Procedure Type
      • 7.3.3.2.4. By End-use
  • 7.3.4. Italy Ligation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Procedure Type
      • 7.3.4.2.4. By End-use
  • 7.3.5. Spain Ligation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Procedure Type
      • 7.3.5.2.4. By End-use

8. Asia-Pacific Ligation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Procedure Type
  • 8.2.4. By End-use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Ligation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Procedure Type
      • 8.3.1.2.4. By End-use
  • 8.3.2. Japan Ligation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Procedure Type
      • 8.3.2.2.4. By End-use
  • 8.3.3. India Ligation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Procedure Type
      • 8.3.3.2.4. By End-use
  • 8.3.4. South Korea Ligation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Procedure Type
      • 8.3.4.2.4. By End-use
  • 8.3.5. Australia Ligation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Procedure Type
      • 8.3.5.2.4. By End-use

9. South America Ligation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Procedure Type
  • 9.2.4. By End-use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Ligation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Procedure Type
      • 9.3.1.2.4. By End-use
  • 9.3.2. Argentina Ligation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Procedure Type
      • 9.3.2.2.4. By End-use
  • 9.3.3. Colombia Ligation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Procedure Type
      • 9.3.3.2.4. By End-use

10. Middle East and Africa Ligation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Procedure Type
  • 10.2.4. By End-use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Ligation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Procedure Type
      • 10.3.1.2.4. By End-use
  • 10.3.2. Saudi Arabia Ligation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Procedure Type
      • 10.3.2.2.4. By End-use
  • 10.3.3. South Africa Ligation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Procedure Type
      • 10.3.3.2.4. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Medtronic Plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. The Cooper Companies, Inc.
• 14.3. Conmed Corporation
• 14.4. B Braun Melsungen AG
• 14.5. Teleflex Incorporated
• 14.6. Olympus Corporation
• 14.7. Ethicon, Inc.
• 14.8. Sinolinks Medical Innovatoin, Inc.
• 14.9. Duomed Group
• 14.10. Leo Medical Co.,Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer